Nicotinic α4β2 Receptor Neurons

Nicotinic Acetylcholine Receptor Neurons (α4β2)

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Nicotinic α4β2 Receptor Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Receptor neurons</td>
</tr>
<tr>
<td class="label">Neurotransmitter</td>
<td>Acetylcholine (ACh)</td>
</tr>
<tr>
<td class="label">Receptor</td>
<td>nAChR α4β2</td>
</tr>
<tr>
<td class="label">Genes</td>
<td>CHRNA4, CHRNB2</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>Prefrontal cortex, hippocampus, thalamus, basal ganglia, striatum</td>
</tr>
<tr>
<td class="label">Ion Selectivity</td>
<td>Na+, K+, Ca2+</td>
</tr>
<tr>
<td class="label">Stoichiometry</td>
<td>(α4)2(β2)3 or (α4)3(β2)2</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
</table>

Introduction

Nicotinic Α4Β2 Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

...

Nicotinic Acetylcholine Receptor Neurons (α4β2)

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Nicotinic α4β2 Receptor Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Receptor neurons</td>
</tr>
<tr>
<td class="label">Neurotransmitter</td>
<td>Acetylcholine (ACh)</td>
</tr>
<tr>
<td class="label">Receptor</td>
<td>nAChR α4β2</td>
</tr>
<tr>
<td class="label">Genes</td>
<td>CHRNA4, CHRNB2</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>Prefrontal cortex, hippocampus, thalamus, basal ganglia, striatum</td>
</tr>
<tr>
<td class="label">Ion Selectivity</td>
<td>Na+, K+, Ca2+</td>
</tr>
<tr>
<td class="label">Stoichiometry</td>
<td>(α4)2(β2)3 or (α4)3(β2)2</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
</table>

Introduction

Nicotinic Α4Β2 Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

α4β2 nicotinic acetylcholine receptors (nAChRs) are the most abundant central nervous system nicotinic receptors, primarily located in the cortex, hippocampus, thalamus, and basal ganglia. These ligand-gated ion channels play critical roles in cognitive enhancement, attention, memory, and are the primary target for nicotine addiction. They have significant implications for neurodegenerative diseases including Alzheimer's disease (AD) and Parkinson's disease (PD). [@balfour2016]

Overview

Multi-Taxonomy Classification

Taxonomy Database Cross-References

External Database Links

• [Cell Ontology (CL:0000197)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)
• [OBO Foundry (CL:0000197)](http://purl.obolibrary.org/obo/CL_0000197)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Molecular Structure and Function

Receptor Architecture

The α4β2 nAChR is a pentameric ligand-gated ion channel:

• α4 subunits: Contain the principal binding site for acetylcholine and nicotine
• β2 subunits: Contribute to complementary binding sites
• Stoichiometry variability: (α4)2(β2)3 (low sensitivity) vs (α4)3(β2)2 (high sensitivity)
• Desensitization: Rapid desensitization upon agonist binding (D, D)

Ion Channel Properties

• Permeability: Na+ > K+ > Cs+; significant Ca2+ permeability (4-8% of total current)
• Single channel conductance: 30-50 pS
• Recovery from desensitization: Slow (seconds to minutes)
• Voltage dependence: Mild inward rectification

Signaling Mechanisms

Fast Synaptic Transmission

• Activation: Acetylcholine binding triggers channel opening within microseconds
• Current kinetics: Fast rise (1-10 ms), brief duration (10-100 ms)
• Termination: Rapid hydrolysis by acetylcholinesterase (AChE)

Calcium Signaling

• Ca2+ influx: Direct Ca2+ permeability through the channel pore
• Second messenger activation: Ca2+ activates calmodulin, CaMKII
• Gene transcription: CREB phosphorylation and BDNF expression
• Synaptic plasticity: LTP) and LTD modulation

Modulatory Effects

• Presynaptic regulation: Ca2+ entry triggers neurotransmitter release
• Postsynaptic excitation: Direct depolarization
• Network oscillations: Theta and gamma rhythm modulation

Distribution in the Brain

Cortical Expression

• Layer V pyramidal neurons: High α4β2 expression
• Interneurons: Cholinergic modulation of inhibition
• Temporal cortex: Particularly dense in auditory and visual cortices

Hippocampal Localization

• CA1 pyramidal cells: Synaptic plasticity modulation
• Dentate gyrus granule cells: Memory encoding
• Interneurons: Feedforward inhibition control

Basal Ganglia

• Striatal medium spiny neurons: Motor learning and habit formation
• Globus pallidus: Motor control
• Substantia nigra pars compacta: Dopaminergic neuron modulation

Thalamic nuclei

• Relay nuclei: Sensory and motor signal transmission
• Intralaminar nuclei: Arousal and attention

Physiological Functions

Cognitive Enhancement

• Attention: Improved selective and sustained attention
• Working memory: Enhanced prefrontal cortical function
• Episodic memory: Hippocampal-dependent memory consolidation
• Executive function: Planning, decision-making, cognitive flexibility

Motor Control

• Basal ganglia function: Habit learning and motor execution
• Movement initiation: Coordination of voluntary movements
• Motor learning: Skill acquisition and refinement

Arousal and Wakefulness

• Thalamocortical activation: Maintains cortical arousal
• REM sleep: Cholinergic activation during REM sleep
• Attention states: Vigilance and alertness modulation

Clinical Significance

Alzheimer's Disease

The α4β2 nAChR is a key therapeutic target in AD:

• Cognitive benefits: Nicotine and α4β2 agonists improve attention and memory
• Neuroprotection: Activation reduces Aβ toxicity and neuroinflammation
• Cholinergic hypothesis: Loss of basal forebrain cholinergic neurons reduces ACh, making α4β2 targeting crucial
• Clinical trials: Nicotine patches showed cognitive benefits in MCI; varenicline trials ongoing
• α4β2 PAMs: Positive allosteric modulators in development for enhanced drug profiles
• Combination therapy: AChE inhibitors (donepezil, rivastigmine) + α4β2 modulators

Parkinson's Disease

• Motor symptoms: Nicotinic agonists may improve motor function
• Neuroprotection: Nicotine may protect dopaminergic neurons
• Levodopa-induced dyskinesia: α4β2 modulation may reduce dyskinesias
• Clinical trials: Nicotine patches showed modest benefits in early PD
• Smoking paradox: Reduced PD risk in smokers (protective effect of nicotine)

Nicotine Addiction

• Primary target: α4β2 is the main nicotinic receptor mediating nicotine addiction
• Desensitization: Chronic nicotine causes receptor desensitization
• Upregulation: Chronic exposure increases receptor density
• Withdrawal: Receptor availability reduction contributes to withdrawal symptoms

Other Neurological Conditions

• ADHD: α4β2 agonists (nicotine, ABT-418) improve attention
• Schizophrenia: Cognitive deficits may benefit from α4β2 modulation
• Epilepsy: Altered α4β2 expression in epileptic tissue
• Tourette's syndrome: Nicotinic agonists reduce tics

Therapeutic Implications

Drug Development

Agonists

• Nicotine: Transdermal patches, gum, lozenges for cognitive enhancement
• Varenicline: Partial agonist, FDA-approved for smoking cessation
• ABT-418: Selective α4β2 agonist, cognitive enhancement
• TC-1734: α4β2 agonist, memory enhancement

Positive Allosteric Modulators (PAMs)

• Type I PAMs: Enhance desensitization kinetics
• Type II PAMs: Slow desensitization, enhance efficacy
• Advantage: Preserve temporal signaling patterns

Antagonists

• Mecamylamine: Non-selective nAChR antagonist
• Dihydro-β-erythroidine: Selective α4β2 antagonist

Challenges

• Side effects: Cardiovascular, gastrointestinal, nausea
• Desensitization: Agonist efficacy decreases with chronic use
• Therapeutic window: Narrow between cognitive enhancement and side effects

Research Methods

Receptor Localization

• Autoradiography: 3Hnicotine and 125Iα-bungarotoxin binding
• In situ hybridization: CHRNA4 and CHRNB2 mRNA expression
• Immunohistochemistry: α4 and β2 subunit antibodies

Functional Studies

• Patch clamp: Whole-cell and single-channel recordings
• Calcium imaging: Fluo-4 in neurons expressing α4β2
• Radioligand binding: 3Hvarenicline, 3Hnicotine saturation

Behavioral Models

• Morris water maze: Spatial memory
• Radial arm maze: Working memory
• Attention tasks: Five-choice serial reaction time

Background

The study of Nicotinic Α4Β2 Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [CHRNA4 Gene - NCBI](https://www.ncbi.nlm.nih.gov/gene/1137)
• [CHRNB2 Gene - NCBI](https://www.ncbi.nlm.nih.gov/gene/1145)
• [α4β2 Receptor - UniProt](P43681, P17787)
• [Nicotinic Acetylcholine Receptor - Wikipedia](https://en.wikipedia.org/wiki/Nicotinic_acetylcholine_receptor)](/entities/acetylcholine)
• [IUPHAR nAChR Family](https://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=1)

See Also

• [Principal Pars Compacta](/wiki/cell-types-principal-pars-compacta) — associated_with
• [Principal Pars Compacta](/wiki/cell-types-principal-pars-compacta) — expressed_in
• [Principal Pars Compacta](/wiki/cell-types-principal-pars-compacta) — inhibits
• [ADAM10 — A Disintegrin And Metalloproteinase Domain 10](/wiki/genes-adam10) — inhibits

Pathway Diagram

The following diagram shows the key molecular relationships involving Nicotinic α4β2 Receptor Neurons discovered through SciDEX knowledge graph analysis: